EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The role of circular RNA during the urological cancer metastasis: exploring regulatory mechanisms and potential therapeutic targets

Yan Xu, Zhipeng Gao, Xiaoyu Sun, Jun Li, Toshinori Ozaki, Du Shi, Meng Yu, Yuyan Zhu

Cancer and Metastasis Reviews · 2024

DOI: 10.1007/s10555-024-10182-x ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer and Metastasis Reviews, 2024. Verfasst von Yan Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Hospital of China Medical University, Shenyang, 110001, China. Hauptthemen laut MEDLINE: RNA, Circular, Urologic Neoplasms, Neoplasm Metastasis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 164 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metastasis is a major contributor to treatment failure and death in urological cancers, representing an important biomedical challenge at present. Metastases form as a result of cancer cells leaving the primary site, entering the vasculature and lymphatic vessels, and colonizing clones elsewhere in the body. However, the specific regulatory mechanisms of action underlying the metastatic process of urological cancers remain incompletely elucidated. With the deepening of research, circular RNAs (circRNAs) have been found to not only play a significant role in tumor progression and prognosis but also show aberrant expression in various tumor metastases, consequently impacting tumor metastasis through multiple pathways. Therefore, circRNAs are emerging as potential tumor markers and treatment targets. This review summarizes the research progress on elucidating how circRNAs regulate the urological cancer invasion-metastasis cascade response and related processes, as well as their role in immune microenvironment remodeling and circRNA vaccines. This body of work highlights circRNA regulation as an emerging therapeutic target for urological cancers, which should motivate further specific research in this regard.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, CircularUrologic NeoplasmsNeoplasm MetastasisHumansAnimalsTumor MicroenvironmentGene Expression Regulation, NeoplasticBiomarkers, Tumor

Stichwörter der Autor:innen

BiomarkersBladder cancerCircRNAMetastasisProstate cancerRenal cell carcinomaTherapeutic targets

Substanzen

RNA, CircularBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Urology, The First Hospital of China Medical University, Shenyang, 110001, China.
  • Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, 110001, China.
  • Laboratory of DNA Damage Signaling, Chiba Cancer Center Research Institute, Chiba, Japan.
  • Department of Urology, The First Hospital of China Medical University, Shenyang, 110001, China. dushi@cmu.edu.cn.
  • Department of Laboratory Animal Science, China Medical University, No. 77 Puhe Road, Shenyang, 110122, Liaoning, China. yumeng@cmu.edu.cn.
  • Department of Urology, The First Hospital of China Medical University, Shenyang, 110001, China. yyzhu@cmu.edu.cn.

Zitieren

APA

Xu, Y., Gao, Z., Sun, X., Li, J., Ozaki, T., Shi, D., Yu, M., & Zhu, Y. (2024). The role of circular RNA during the urological cancer metastasis: exploring regulatory mechanisms and potential therapeutic targets. Cancer and Metastasis Reviews. https://doi.org/10.1007/s10555-024-10182-x

Vancouver

Xu Y, Gao Z, Sun X, Li J, Ozaki T, Shi D, et al. The role of circular RNA during the urological cancer metastasis: exploring regulatory mechanisms and potential therapeutic targets. Cancer and Metastasis Reviews. 2024. doi:10.1007/s10555-024-10182-x

BibTeX
@article{Xu2024,
  author = {Xu, Yan and Gao, Zhipeng and Sun, Xiaoyu and Li, Jun and Ozaki, Toshinori and Shi, Du and Yu, Meng and Zhu, Yuyan},
  title = {The role of circular RNA during the urological cancer metastasis: exploring regulatory mechanisms and potential therapeutic targets},
  journal = {Cancer and Metastasis Reviews},
  year = {2024},
  doi = {10.1007/s10555-024-10182-x}
}
Kostenlos starten →